Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > The Phase 2 False Start

<< Previous

Bullboard Posts

Next >>

Comment by robertshawon Dec 11, 2020 2:41pm

147 Views

Post# 32089957

RE:RE:RE:RE:The Phase 2 False Start

Johnandrose22 wrote: It seems to me that the clinical protocol was developed, refined and optimized with Phase I patients 5&6. Whoever revised, manipulated, “mistook” or “mislead” this protocol going into Phase II has a lot to answer for.

Blowjobjoe's boss has a lot to answer that.

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?